References
1. Polikarova O.V., Kalita A.A., Ushakova O.V. Pharmacotherapy during pregnancy. Regional State Budgetary Healthcare Institution "Clinical Diagnostic Center" of the Ministry of Health of the Khabarovsk Territory, dated 07.02.2018. (in Russian)
2. Treating for Two: A National Strategy for Safer Medication Use in Pregnancy. Centers for Disease Control and Prevention, USA, 2020.
3. Mehmood Z., et al. A cross-sectional research study on over the counter (Otc) self-medication usage in the case of pregnancy before, during or after with possible adversative results. IAJPS. 2018; 5 (10): 10 445-52.
4. Raebel M.A. et al. Prescribing safety during pregnancy. J Am Med Inform Assoc. 2007; 14 (4): 440-50.
5. Carp H.J.A. The fear of Drugs in Pregnancy: Justified or Exaggerated Sheba Medical Centre, Tel Hashomer and Tel Aviv University, Israel, 2019.
6. Polykarpova J.V., Kalita A.A., Ushakova O.V. Pharm therapy in pregnancy. Zdravookhraneniye Dal'nego Vostoka [Public Health of the Far East]. 2014; 3 (61): 3-13. (in Russian)
7. Tsimmerman Y.S., Mikhaleva E.N. Possibilities for pharmacotherapy of gastroenterological diseases during pregnancy. Vestnik kluba pankre-atologov.2020. May: 54-63. (in Russian)
8. Radhwan Nidal Al-Zidan. Drugs in Pregnancy: A Handbook for Pharmacists and Physicians. 2020. 402 p.
9. Tsamantioti E.S., Hashmi M.F. Teratogenic Medications. Last Update: January 4, 2020.
10. Reshetko O.V., Lutsevich K.A. Modern aspects of epidemiology of congenital anomalies of development: methodological issues and the translation of research findings into clinical practice. Kachestvennaya klin-icheskaya praktika. 2018; 3: 56-65. DOI: https://doi.org/10.24411/2588-0519-2018-10051 (in Russian)
11. Early pregnancy. From pregravid preparation to healthy gestation / ed. V.E. Radzinsky, A.A. Orazmuradov. Moscow: Redaktsiya zhurnala Sta-tusPraesens, 2018: 133-5 (in Russian)
12. Chukhraeva N.A. Pharmacoepidemiology of drugs for the prevention and treatment of common diseases and syndromes in pregnant women. Autoabstract of Diss. Mоscow, 2016. (in Russian)
13. Radzinsky V.E. Obstetric aggression. Moscow: Izd-vo zhurnala Sta-tusPraesens, 2017. 872 p. (in Russian)
14. Kuandykov E.U., Jumasheva R.T., Almuhambetova S.K., Zhumagul M.Zh. Pregnancy and medicines. Vestnik КаzNМU. 2018; 1. (in Russian)
15. da Silva W.E., de Melo I.M.F., de Albuquerque Y.M.L., Mariano A.F.D.S., Wanderley-Teixeira V., Teixeira A.A.C. Effect of metronidazole on placental and fetal development in albino rats. Anim Reprod. 2019; 16 (4): 810-8. DOI: https://doi.org/10.21451/1984-3143-AR2018-0149
16. Bellos I., Pergialiotis V., Papapanagiotou A., Loutradis D., Daska-lakis G. Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis. Am J Obstet Gynecol. 2020 Mar 19. PII: S0002-9378(20)30338-0. DOI: https://doi.org/10.1016/j.ajog.2020.03.016
17. Hod M., Kapur A., Sacks D.A., et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015; 131 (suppl. 3): S173-S211. DOI: https://doi.org/10.1016/S0020-7292(15)30033-3
18. Dedov I.I., Krasnopolsky V.I., Sukhikh G.T. on behalf of the working group. Russian national consensus "Gestational diabetes mellitus: diagnosis, treatment, postpartum follow-up". Diabetes mellitus. 2012; (4): 4-10. (in Russian)
19. Sazonova A.I., Esayan R.M., Kolegaeva O.I., Gardanova Z.R. Efficacy and safety of metformin for the treatment of gestational diabetes: a new approach to the problem. Diabetes Mellitus. 2016; 19 (2): 164-70. (in Russian)